Seltsam Axel, Doescher Andrea
Institute Springe, Blood Center of the German Red Cross Chapters of NSTOB, Germany.
Transfus Med Hemother. 2009;36(3):204-212. doi: 10.1159/000217322. Epub 2009 May 14.
In the last two decades, all but one of the genes encoding the 30 blood group systems present on red blood cells have been identified. This body of knowledge has permitted the application of molecular techniques to characterize the common blood group antigens and to elucidate the background for some of the variant phenotypes. DNA sequencing methodology was developed in the late 1970s and has become one of the most widely used techniques in molecular biology. In the field of immunohematology, this method is currently used by specialized laboratories to elucidate the molecular basis of unusual blood group phenotypes that cannot be defined by serology and genotyping. Because of the heterogeneity of the blood groups on both the antigen and the genetic level, special knowledge of the biology of blood group systems is needed to design sequencing strategies and interpret sequence data. This review summarizes the technical and immunohematologic expertise that is required when applying sequence-based typing for characterization of human blood groups.
在过去的二十年里,编码红细胞上存在的30种血型系统的基因,除一种外其余均已被鉴定出来。这一知识体系使得分子技术得以应用于表征常见血型抗原,并阐明一些变异表型的背景。DNA测序方法是在20世纪70年代末开发的,现已成为分子生物学中使用最广泛的技术之一。在免疫血液学领域,目前专业实验室使用这种方法来阐明无法通过血清学和基因分型定义的异常血型表型的分子基础。由于血型在抗原和基因水平上的异质性,设计测序策略和解释序列数据需要对血型系统生物学有专门的知识。本综述总结了应用基于序列的分型来表征人类血型时所需的技术和免疫血液学专业知识。